Literature DB >> 9042124

Nitric oxide inhalation in infants with respiratory distress syndrome.

J W Skimming1, K A Bender, A A Hutchison, W H Drummond.   

Abstract

OBJECTIVE: This study was designed to test the hypothesis that nitric oxide inhalation increases systemic arterial blood oxygen tension of prematurely delivered infants with respiratory distress syndrome.
METHODS: Nitric oxide was administered to 23 preterm infants with a diagnosis of respiratory distress syndrome. The infants were randomly assigned to receive either 5 or 20 ppm of nitric oxide and were studied between 24 and 168 hours after delivery. The treatment period for each infant lasted 15 minutes and was preceded by and followed by a 15-minute control period. We evaluated all outcome variables by using two-way repeated measures analysis of variance; p values less than 0.01 were considered significant.
RESULTS: Nitric oxide inhalation caused significant increases in the following: arterial blood oxygen tension, directly measured arterial oxyhemoglobin saturation, and transcutaneously measured arterial oxyhemoglobin saturation. No differences between the effects of the two nitric oxide concentrations were detected, nor were residual effects detected 15 minutes after either dose of nitric oxide was discontinued.
CONCLUSIONS: Inhalation of both 5 and 20 ppm nitric oxide causes concentration-independent increases in the blood oxygen tensions of preterm infants with respiratory distress syndrome. We speculate that nitric oxide inhalation may be a useful adjunctive therapy for these patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9042124     DOI: 10.1016/s0022-3476(97)70347-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

Review 1.  Response to inhaled nitric oxide in premature and term neonates.

Authors:  T Hoehn; M F Krause
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure.

Authors:  R L Smyth
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

Review 3.  Inhaled nitric oxide and neuroprotection in preterm infants.

Authors:  Jeremy D Marks; Michael D Schreiber
Journal:  Clin Perinatol       Date:  2008-12       Impact factor: 3.430

Review 4.  Inhaled nitric oxide for respiratory failure in preterm infants.

Authors:  Keith J Barrington; Neil Finer; Thomas Pennaforte
Journal:  Cochrane Database Syst Rev       Date:  2017-01-03

Review 5.  Providing a Placental Transfusion in Newborns Who Need Resuscitation.

Authors:  Anup C Katheria; Melissa K Brown; Wade Rich; Kathy Arnell
Journal:  Front Pediatr       Date:  2017-01-25       Impact factor: 3.418

Review 6.  The Controversy Persists: Is There a Qualification Criterion to Utilize Inhaled Nitric Oxide in Pre-term Newborns?

Authors:  Frederico Vieira; Marjorie Makoni; Edgardo Szyld; Krishnamurthy Sekar
Journal:  Front Pediatr       Date:  2021-03-31       Impact factor: 3.418

Review 7.  Placental transfusion: a review.

Authors:  A C Katheria; S Lakshminrusimha; H Rabe; R McAdams; J S Mercer
Journal:  J Perinatol       Date:  2016-09-22       Impact factor: 2.521

8.  Persistent pulmonary hypertension in an extremely low birth weight infant.

Authors:  Saleh Al-Alaiyan; Husam Salama; Khalid Attas
Journal:  Ann Saudi Med       Date:  2004 Jan-Feb       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.